Recovery is real, but medical costs still bite
- Management lifted 2026 adjusted EPS guidance to $19.50-$20.00 after a stronger Q2.
- Medicare Advantage trends are better than planned, with 2026 margins expected above 3%.
- Commercial medical cost trends are now modestly above 11%, delaying full margin recovery.
- Medicare Advantage membership is expected to fall by about 1.1 million as UnitedHealth protects margins.
- Optum Rx expects to end 2026 with more than 95% of clients on a 100% rebate pass-through model.
A reset that is starting to work
UnitedHealth is coming out of a hard 2025, when medical costs were priced badly and earnings fell. The latest update is better. Management raised 2026 adjusted EPS guidance to $19.50-$20.00, and Medicare Advantage, the private Medicare plans sold to seniors, is running better than the company expected.
The bull case is that 2025 was the bottom. UnitedHealth cut weaker Medicare Advantage business, changed benefits, tightened networks, and pushed Optum Health back toward more disciplined value-based care, where providers are paid to manage total patient cost and quality. If those fixes hold, earnings can rebuild from a lower but cleaner base.
The bear case is still serious. Commercial medical costs are modestly above 11%, helped by pressure from the No Surprises Act independent dispute resolution process, a system for settling out-of-network bills. That means the company may fix Medicare while employer plans keep dragging on profit.
Finn's view is balanced. UnitedHealth has scale, cash flow, and a clearer recovery path, but the stock still depends on medical cost control that has already failed once.
Premiums, care, drugs, and data
UnitedHealth has two main engines. UnitedHealthcare sells health plans to employers, individuals, Medicare members, and Medicaid programs. Most of that money comes from premiums, and profit depends on whether premiums are high enough to cover doctor, hospital, and drug claims.
Optum is the services side. Optum Health delivers care through clinics, doctors, and home programs. Optum Rx is a pharmacy benefit manager, or PBM, which helps clients manage drug costs. Optum Insight sells technology, data, analytics, and consulting to health systems and payers.
The model works best when the two sides help each other. UnitedHealthcare brings scale and claims data. Optum can use care management, pharmacy tools, and analytics to lower costs. That loop is the moat, but it also creates scrutiny because UnitedHealth touches many parts of the health system.
The main break point is simple: medical costs can move faster than pricing. In 2026, Medicare Advantage looks better than plan, but Commercial trends are still too high. Optum Rx is also shifting toward transparency, with a commitment to pass through 100% of negotiated rebates to clients by 2028.
Where UnitedHealth competes
UnitedHealthcare Employer and Individual
This is the commercial insurance business for employers and individuals. It is large, but current medical cost trends are modestly above 11%, so pricing has to catch up.
UnitedHealthcare Medicare Advantage
These are private Medicare plans for seniors. UnitedHealth expects about 1.1 million fewer Medicare Advantage members in 2026 as it trades growth for better margins.
UnitedHealthcare Medicaid
This business manages care for state Medicaid programs. The Q1 filing noted pressure from behavioral, pharmacy, and home health costs, plus timing gaps in state rate updates.
Optum Health
Optum Health provides direct care and value-based care. The turnaround is gaining traction, but the business still has execution risk after growing too fast in prior years.
Optum Rx
Optum Rx manages pharmacy benefits and specialty pharmacy services. It is moving toward fee-based and rebate pass-through contracts as buyers demand clearer pricing.
Optum Insight
Optum Insight sells data, software, analytics, and consulting. Management is reinvesting here, including AI-enabled tools, while Optum Financial moved into this segment in 2026.
Insurance still dominates the mix
Segment mix uses Q1 2026 unaffiliated customer revenue from the 10-Q, so Optum revenue from UnitedHealthcare is excluded to avoid double counting. UnitedHealthcare was the largest segment by far.
What could break the recovery
Medical costs outrun pricing again
High impact · Medium oddsUnitedHealth earns money only if premiums and government payments cover the care people use. The company already admitted that 2025 pricing and health-status assumptions missed actual medical costs. A second miss would damage trust in the recovery.
Commercial IDR pressure stays high
High impact · High oddsCommercial cost trends are modestly above 11%. Management points to No Surprises Act independent dispute resolution and provider billing intensity as key causes. If that process is not fixed, Commercial margins may stay below old levels for longer than investors expect.
Optum Health turnaround stalls
Medium impact · Medium oddsOptum Health is trying to fix value-based care after growing too fast and taking the wrong kinds of risk. The plan includes narrower networks, exits from weak products, and tighter care management. If hospitalizations or patient mix worsen, margin gains may fade.
Regulators or courts hit the model
High impact · Medium oddsUnitedHealth is deeply regulated because it sells insurance, manages drugs, runs care assets, and handles health data. It also faces routine legal actions and government investigations, including claims practices, antitrust, Medicare coding, and False Claims Act matters. Large penalties or forced business changes could lower earnings power.
Another major cyber event
High impact · Medium oddsUnitedHealth depends on health data, claims systems, and pharmacy systems. The 2024 Change Healthcare cyberattack showed that a technology failure can disrupt providers, patients, and payments. A repeat event would bring direct costs and reputational damage.
In one breath
What does UnitedHealth actually do?
UnitedHealth sells health insurance through UnitedHealthcare and runs health services through Optum. Optum includes care delivery, pharmacy benefit management, and data and technology services.
Why did UnitedHealth have to reset in 2025?
Medical costs ran much higher than the company had priced for. Management has since cut weaker membership, changed benefits, tightened networks, and focused on margin recovery.
What is the biggest thing to watch now?
Watch whether Commercial medical cost trends cool down. Medicare Advantage is improving, but Commercial costs above plan could keep overall margins under pressure.
Is Optum good or bad for UnitedHealth?
Optum is a major strength when it lowers care and drug costs for clients. It is also a risk because Optum Health has complex value-based care contracts, and Optum Rx faces pricing scrutiny.